Calcitonin originated from platypus and application thereof

A technology of calcitonin and platypus, which is applied in the field of biomedicine, can solve the problems of heavy burden of medical expenses for patients, limited calcitonin, and large clinical dosage, so as to reduce clinical dosage, lower serum calcium content, and significantly reduce The effect of blood calcium bioactivity

Inactive Publication Date: 2017-06-20
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Although salmon calcitonin, human calcitonin and other preparations have been widely used clinically, due to the limitation of the activity of calcitonin, the general clinical use is relatively large, resulting in high production costs and heavy burden of medical expenses for patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Calcitonin originated from platypus and application thereof
  • Calcitonin originated from platypus and application thereof
  • Calcitonin originated from platypus and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Example 1: Obtain calcitonin sequence by BLAST and construct phylogenetic tree

[0026] Using the salmon calcitonin sequence (CSNLSTCVLGKLSQELHKLQTYPRTNTGSGTP) as the query sequence, the blastp program of BLAST was used to search the non-redundant protein database in the NCBI database, and the large yellow croaker, hippocampus, grouper, three species of golden-thread barb, Arowana and two A local BLAST comparison of the genomes of aquatic organisms such as Mudskipper and a total of 68 protein sequences from different species was obtained, 13 of which were from aquatic organisms.

[0027] Further analysis of the sequences found that there were many repetitions in the amino acid sequences of the alignment segments corresponding to 32 amino acids of salmon calcitonin among the 68 protein sequences. 27 different calcitonin polypeptide sequences (SEQ ID NO.1-SEQ ID NO.27) including the calcitonin sequence.

[0028] Then, utilize the neighbor-joining (N-J) method of MEGA 5 (...

Embodiment 2

[0034] Example 2: Solid phase chemical synthesis of calcitonin polypeptide

[0035] The structure of platypus-derived calcitonin is as follows:

[0036] Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Asn-Pro-Arg-Thr- Asp-Val-Gly-Ala-Gly-Thr-Pro-NH 2 .

[0037] In the above amino acid sequence, Pro-NH2 represents prolinamide, and the two Cys residues at positions 1 and 7 are connected by a disulfide bond.

[0038] The 27 calcitonin polypeptides involved in Example 1 of the present invention were synthesized by a solid-phase or liquid-phase method. In this example, the synthesis of platypus-derived calcitonin by Fmoc (9-fluorenylmethoxycarbonyl) solid-phase synthesis method is used as an example to illustrate the polypeptide synthesis process, but it is not limited to this method for polypeptide synthesis. The steps are as follows:

[0039] (1) Select (2,4-dimethoxyphenyl-Fmoc-aminomethyl)-phenoxyacetamido-norleucyl-MBHA resin (i.e. Rink ...

Embodiment 3

[0046] Example 3: Purification and Mass Spectrometry Identification of Calcitonin Polypeptide by High Performance Liquid Chromatography (HPLC)

[0047] The platypus-derived calcitonin polypeptide obtained in Example 2 was purified by reverse-phase high-performance liquid chromatography (RP-HPLC). The purification conditions are as follows: the chromatographic column is a C18 reversed-phase column (Hichrom Vydac 218TPTM C-18Reversed-PhaseColumns, 5μm, 4.6mm i.d.x 250mm), mobile phase A is 0.1%TFA-100%H 2 O, mobile phase B is 0.1% TFA-100% CNCH 3 , the flow rate is 1ml / min, the linear elution gradient is from 20% to 90% of mobile phase B within 30min, and from 90% to 100% of mobile phase B within 5min.

[0048] Such as figure 2 As shown, the obtained platypus-derived calcitonin polypeptide was identified by HPLC, and its purity reached more than 96%. Such as image 3 As shown, the identification result of ESI mass spectrometry is in line with the theoretical value, the mo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Weightaaaaaaaaaa
Login to View More

Abstract

The invention relates to calcitonin originated from platypus and an application thereof. The amino acid sequence of the calcitonin is as follows: Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Leu-His-Lys-Leu-Gln-Thr-Asn-Pro-Arg-Thr-Asp-Val-Gly-Ala-Gly-Thr-Pro-NH2, wherein Pro-NH2 represents prolinamide. Two Cys residual groups on the first and seventh sites are connected through a disulfide bond and the calcitonin is synthesized by means of an Fmoc solid phase synthetic method. The calcitonin originated from platypus, provided by the invention, can be used for preparing a medicine for adjusting calcium and phosphorus metabolism in vivo or a medicine for treating or preventing bone metabolic and / or calcium metabolic disorder related diseases. Therefore, the invention also relates to a pharmaceutical composition which takes the calcitonin originated from platypus as a basic component.

Description

technical field [0001] The invention belongs to the field of biomedicine, and in particular relates to a new calcitonin polypeptide derived from platypus (Lepisosteusoculatus) and having the activity of reducing serum calcium ion concentration, a pharmaceutical composition containing the peptide, and the composition in the treatment of bone metabolism and / or Calcium metabolism disorders and other related diseases. Background technique [0002] Calcitonin (CT), discovered by Canadian physiologist Coop in 1961, is a peptide hormone that regulates the metabolism of calcium and phosphorus in the body. It mainly plays a role in reducing blood calcium and blood phosphorus. The specific mechanism is: inhibit the function of osteoclasts through calcitonin receptor (CTR), inhibit bone resorption, reduce the release of calcium and phosphorus in bone tissue; inhibit the release of calcium, phosphorus, sodium and chloride by renal tubules Reabsorption, increasing their excretion in uri...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/585C07K1/20C07K1/06C07K1/04A61K38/23A61P3/12A61P3/14A61P19/08A61P19/10A61P29/00
CPCY02P20/55C07K14/585A61K38/00
Inventor蔡在龙杨生生胡杰伟陈圆圆俞瑾李安吉
OwnerSECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY